122 related articles for article (PubMed ID: 29959919)
1. LncRNA EPIC1 protects human osteoblasts from dexamethasone-induced cell death.
Zhang XY; Shan HJ; Zhang P; She C; Zhou XZ
Biochem Biophys Res Commun; 2018 Sep; 503(4):2255-2262. PubMed ID: 29959919
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA MALAT1 Protects Human Osteoblasts from Dexamethasone-Induced Injury via Activation of PPM1E-AMPK Signaling.
Fan JB; Zhang Y; Liu W; Zhu XH; Xu DW; Zhao JN; Cui ZM
Cell Physiol Biochem; 2018; 51(1):31-45. PubMed ID: 30439702
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA EPIC1 promotes human lung cancer cell growth.
Zhang B; Lu HY; Xia YH; Jiang AG; Lv YX
Biochem Biophys Res Commun; 2018 Sep; 503(3):1342-1348. PubMed ID: 30029875
[TBL] [Abstract][Full Text] [Related]
4. LncRNA EPIC1 downregulation mediates hydrogen peroxide-induced neuronal cell injury.
Sun J; Zheng J; Li Y; Yan M; Li P; Ma L
Aging (Albany NY); 2019 Dec; 11(23):11463-11473. PubMed ID: 31812951
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
Li Y; Cai Q; Li W; Feng F; Yang L
Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
[TBL] [Abstract][Full Text] [Related]
6. Targeting LncRNA EPIC1 to inhibit human colon cancer cell progression.
Wu Q; Wei J; Zhao C; Xiang S; Shi M; Wang Y
Aging (Albany NY); 2020 Nov; 15(2):583-594. PubMed ID: 33170148
[TBL] [Abstract][Full Text] [Related]
7. microRNA-7 inhibition protects human osteoblasts from dexamethasone via activation of epidermal growth factor receptor signaling.
Fan JB; Liu W; Zhu XH; Cui SY; Cui ZM; Zhao JN
Mol Cell Biochem; 2019 Oct; 460(1-2):113-121. PubMed ID: 31313024
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone-induced cytotoxicity in human osteoblasts is associated with circular RNA HIPK3 downregulation.
Zhu CY; Yao C; Zhu LQ; She C; Zhou XZ
Biochem Biophys Res Commun; 2019 Aug; 516(3):645-652. PubMed ID: 31242973
[TBL] [Abstract][Full Text] [Related]
9. MYC-binding lncRNA EPIC1 promotes AKT-mTORC1 signaling and rapamycin resistance in breast and ovarian cancer.
Wang Y; Zhang M; Wang Z; Guo W; Yang D
Mol Carcinog; 2020 Oct; 59(10):1188-1198. PubMed ID: 32810332
[TBL] [Abstract][Full Text] [Related]
10. PGK1 depletion activates Nrf2 signaling to protect human osteoblasts from dexamethasone.
Liang J; Zhang XY; Zhen YF; Chen C; Tan H; Hu J; Tan MS
Cell Death Dis; 2019 Nov; 10(12):888. PubMed ID: 31767834
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of cPWWP2A-miR-579 axis mediates dexamethasone-induced cytotoxicity in human osteoblasts.
Hong H; Sun Y; Deng H; Yuan K; Chen J; Liu W; Cui Z
Biochem Biophys Res Commun; 2019 Sep; 517(3):491-498. PubMed ID: 31376935
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells.
Xia P; Liu P; Fu Q; Liu C; Luo Q; Zhang X; Cheng L; Qin T; Zhang H
Biochem Biophys Res Commun; 2020 Feb; 522(4):978-985. PubMed ID: 31810603
[TBL] [Abstract][Full Text] [Related]
13. microRNA-25 targets PKCζ and protects osteoblastic cells from dexamethasone via activating AMPK signaling.
Fan JB; Liu W; Zhu XH; Yi H; Cui SY; Zhao JN; Cui ZM
Oncotarget; 2017 Jan; 8(2):3226-3236. PubMed ID: 27911275
[TBL] [Abstract][Full Text] [Related]
14. Phosphoglycerate kinase 1 silencing by a novel microRNA microRNA-4523 protects human osteoblasts from dexamethasone through activation of Nrf2 signaling cascade.
Liang JQ; Zhou ZT; Bo L; Tan HN; Hu JH; Tan MS
Cell Death Dis; 2021 Oct; 12(11):964. PubMed ID: 34667156
[TBL] [Abstract][Full Text] [Related]
15. OSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK Signaling.
Xu D; Zhao W; Zhu X; Fan J; Cui S; Sun Y; Chen X; Liu W; Cui ZM
PLoS One; 2016; 11(9):e0162694. PubMed ID: 27632213
[TBL] [Abstract][Full Text] [Related]
16. miR-107 inhibition upregulates CAB39 and activates AMPK-Nrf2 signaling to protect osteoblasts from dexamethasone-induced oxidative injury and cytotoxicity.
Zhuang Y; Wang S; Fei H; Ji F; Sun P
Aging (Albany NY); 2020 Jun; 12(12):11754-11767. PubMed ID: 32527986
[TBL] [Abstract][Full Text] [Related]
17. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
Wang Z; Yang B; Zhang M; Guo W; Wu Z; Wang Y; Jia L; Li S; ; Xie W; Yang D
Cancer Cell; 2018 Apr; 33(4):706-720.e9. PubMed ID: 29622465
[TBL] [Abstract][Full Text] [Related]
18. FGF23 protects osteoblasts from dexamethasone-induced oxidative injury.
Ji F; Hu X; Hu W; Hao YD
Aging (Albany NY); 2020 Oct; 12(19):19045-19059. PubMed ID: 33052883
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-induced apoptosis of osteocytic and osteoblastic cells is mediated by TAK1 activation.
Ding H; Wang T; Xu D; Cha B; Liu J; Li Y
Biochem Biophys Res Commun; 2015 May; 460(2):157-63. PubMed ID: 25753204
[TBL] [Abstract][Full Text] [Related]
20. miR-135b expression downregulates Ppm1e to activate AMPK signaling and protect osteoblastic cells from dexamethasone.
Fan JB; Ruan JW; Liu W; Zhu LQ; Zhu XH; Yi H; Cui SY; Zhao JN; Cui ZM
Oncotarget; 2016 Oct; 7(43):70613-70622. PubMed ID: 27661114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
